These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending. Bellanti JA; Settipane RA Allergy Asthma Proc; 2023 Jul; 44(4):217-219. PubMed ID: 37480204 [No Abstract] [Full Text] [Related]
9. Immunization, not vaccination: monoclonal antibodies for infant RSV prevention and the US vaccines for children program. Sevilla JP J Med Econ; 2023; 26(1):991-997. PubMed ID: 37498791 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of RSV-related hospitalisations in children and adults over a 7 year-period before, during and after the COVID-19 pandemic. Kiefer A; Pemmerl S; Kabesch M; Ambrosch A J Clin Virol; 2023 Sep; 166():105530. PubMed ID: 37481874 [TBL] [Abstract][Full Text] [Related]
12. Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink. Katherine Yih W; Daley MF; Duffy J; Fireman B; McClure DL; Nelson JC; Qian L; Smith N; Vazquez-Benitez G; Weintraub E; Williams JTB; Xu S; Maro JC Vaccine; 2023 Aug; 41(36):5265-5270. PubMed ID: 37479610 [TBL] [Abstract][Full Text] [Related]
13. Estimating the full health and economic benefits of current and future influenza vaccines. Lafond KE; Gharpure R; Dugan VG; Azziz-Baumgartner E BMC Med; 2023 Jul; 21(1):273. PubMed ID: 37501176 [TBL] [Abstract][Full Text] [Related]
14. Year-Round Respiratory Syncytial Virus Transmission in The Netherlands Following the COVID-19 Pandemic: A Prospective Nationwide Observational and Modeling Study. Löwensteyn YN; Zheng Z; Rave N; Bannier MAGE; Billard MN; Casalegno JS; Pitzer VE; Wildenbeest JG; Weinberger DM; Bont L; J Infect Dis; 2023 Nov; 228(10):1394-1399. PubMed ID: 37477906 [TBL] [Abstract][Full Text] [Related]
15. Determining the true incidence of seasonal respiratory syncytial virus-confirmed hospitalizations in preterm and term infants in Western Australia. Sarna M; Gebremedhin A; Richmond P; Levy A; Glass K; Moore HC Vaccine; 2023 Aug; 41(36):5216-5220. PubMed ID: 37474407 [TBL] [Abstract][Full Text] [Related]
18. A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus. Hu L; Jiang J; Tang Y; Mei L; Wu L; Li L; Chen H; Long F; Xiao J; Peng T Viruses; 2023 Jul; 15(7):. PubMed ID: 37515234 [TBL] [Abstract][Full Text] [Related]
19. Eosinophils as potential biomarkers in respiratory viral infections. Macchia I; La Sorsa V; Urbani F; Moretti S; Antonucci C; Afferni C; Schiavoni G Front Immunol; 2023; 14():1170035. PubMed ID: 37483591 [TBL] [Abstract][Full Text] [Related]
20. A Zebra Among the Horses: Clinical Implications of Malaria in the United States. Huits R; Wallender E; Angelo KM; Libman M; Hamer DH Ann Intern Med; 2023 Sep; 176(9):1269-1270. PubMed ID: 37487212 [No Abstract] [Full Text] [Related] [Next] [New Search]